Product
rizatriptan
Aliases
Maxalt, MK-0462
2 clinical trials
2 indications
Indication
MigraineIndication
AcuteClinical trial
A Worldwide, Randomized, Double Blind, Placebo-Controlled, Parallel Group Clinical Trial to Evaluate the Safety and Efficacy of Rizatriptan for the Acute Treatment of Migraine in Children and AdolescentsStatus: Completed, Estimated PCD: 2011-04-21
Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Crossover Trial to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg for the Treatment of Acute Migraine in Sumatriptan Non-RespondersStatus: Completed, Estimated PCD: 2010-01-12